View Older Stories View More Recent Stories
-
Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator (DxA) invests $10M in Alamar Biosciences, Inc. to Advance Precision Medicine in Alzheimer's Disease
-
Washington Post to lay off 4% of staff to cut costs
-
Go Rentals CEO Kaye Gitibin Honored at the 22nd Living Legends of Aviation Awards
-
Sierra Space CEO Tom Vice departs as spaceplane nears launch
-
Bezos' Blue Origin gets FAA license for its first New Glenn rocket launch
-
AI-Powered Leap Financial Raises $3.5 Million Seed Round Led By Fuel Venture Capital
-
Elon Musk Is At The Table With Trump And Jeff Bezos For Dinner Tonight At Mar-a-lago - Cbs Reporter Jennifer Jacobs
-
Blue Origin and Estes Rockets Join Forces
-
Factbox-What to expect on Trump's Inauguration Day
-
Trump to meet Netflix co-CEO Ted Sarandos, source says
-
Sports Illustrated's "SI the Party" Returns to Big Game Weekend 2025 Saturday, February 8th, in New Orleans
-
To rival SpaceX’s Starship, ULA eyes Vulcan rocket upgrade
-
Amazon donating $1 million to Trump inaugural fund, to air event on Prime Video
-
Tenstorrent, Hyundai-backed BOS unveil automotive AI chips
-
Trump says he will meet with Amazon's Bezos next week
-
Elon Musk's net worth tops $400 billion, Forbes billionaires list shows
-
Dolly Parton Continues Legacy of Generosity with Second Million-Dollar Donation to The Salvation Army
-
AI startup Perplexity adds The Independent, LA Times to its publishers' program
-
November's Top 10 Celebrity Real Estate News: Richard Gere, Katy Perry and Tom Ford
-
Daron "Dr. Comeback" Fordham, Award-Winning Filmmaker, Screenwriter, Poet and Former Tech CEO, Releases LIFE IS A COMEBACK, an Inspirational Book of Successful Comeback Stories
-
AI startup Perplexity adds shopping features as search competition tightens
-
New Investment from the Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator (DxA) Leads Efforts to Develop Standardization Materials for Leading Diagnostic Biomarker
-
Blue Origin, AST Spacemobile ink New Glenn rocket launch deal
-
Navy SEAL Foundation to Receive Bezos Courage and Civility Award from Admiral William McRaven
-
Children of Fallen Patriots to Receive Bezos Courage and Civility Award Match from Admiral William McRaven
-
How Trump's second administration affects business: Musk, tariffs and more
-
Perplexity raising new funds at $9 billion valuation, source says
-
Amazon's (AMZN) Jeff Bezos Sells $213.8 Million Shares as Part of Trading Plan
-
Robot AI startup Physical Intelligence raises $400 million from Bezos, OpenAI
-
OpenAI adds new search function to ChatGPT
-
October's Top 10 Celebrity Real Estate News: George Clooney, Tom Cruise, David and Victoria Beckham
-
Washington Post's Bezos defends decision to end presidential endorsements
-
Republican senator presses FAA to speed rocket launch license reviews
-
Alphabet's Q3 revenue growth likely to slow as competition pressures Search, YouTube
-
Meta Platforms to use Reuters news content in AI chatbot
-
Perplexity CEO 'surprised' by Dow Jones, New York Post lawsuit against startup
-
"A Kamala Harris Victory Could Impact Markets by 50%," Cautions Financial Expert Jim Rickards
-
TEAMSTERS, MEMBERS OF CONGRESS DEMAND AMAZON STOP IGNORING FEDERAL LAW
-
Perplexity AI in funding talks to more than double valuation to $8 billion, WSJ reports
-
$60 Million Bezos Earth Fund Grant will Revitalize 1.6 Million Acres of Vital U.S. Landscapes
-
AI Ethics Council Welcomes LinkedIn Co-Founder Reid Hoffman and Commentator, Founder and Author Van Jones as Newest Members
-
James Altucher Identifies 'AI 2.0 Wealth Window' as a Potential Wealth Boom for Everyday Americans
-
Thoughtly Responds to Global Debate Over "Founder Mode" Work Culture
-
New report reveals a rise in phishing attacks, as commodity campaigns, advanced persistent threats, and impersonation attacks escalate
-
New report reveals a rise in phishing attacks, as commodity campaigns, advanced persistent threats, and impersonation attacks escalate
-
C2N Receives Funding from Diagnostics Accelerator to Develop a Decentralized Clinical Mass Spectrometry Solution to Enable High-Performance Alzheimer’s Disease Testing Worldwide
-
Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator (DxA) Invests More Than $7 Million in C2N Diagnostics' Blood Tests
-
19 Leading Companies Signal Support for Energy Transition Accelerator
-
Alzheimer's Drug Discovery Foundation Invests in First-of-its-Kind Biomarker Observatory Led by Renowned Clinical Trials Expert to Accelerate Novel Drug Development
-
Japan's Mitsubishi to provide H3 rockets for France's Eutelsat from 2027
